Optimizing Preclinical AAV Safety 2022 Slides by Dr. Victoria

Optimizing Preclinical AAV Safety – Harmonization and Discovery Download the slides from Dr. Victoria Best’s talk at Optimizing AAV Safety 2022 about assessing preclinical safety signals derived from AAV gene therapies.   Synopsis: Opportunities to Expand AAV Safety Data, Benchmarking, and Harmonization at the Preclinical phase Issues the FDA is going to pay more attention […]